Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

AstraZeneca

AstraZeneca
PUBLIC STATUS
60K-65K EMPLOYEES
AZN STOCK SYMBOL
60 INVESTMENTS
$95.25 SHARE PRICE (As of Tuesday Closing)
Description

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The company sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology, and neuroscience. The majority of sales come from international markets with the United States representing close to one third of its sales.

Formerly Known As
Zeneca Group
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Stock Exchange
LON
Primary Office
  • 1 Francis Crick Avenue
  • Cambridge CB2 0RE
  • England, United Kingdom

+44 020 0000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore AstraZeneca’s full profile, request a free trial.

AstraZeneca Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$1.41 - $101.47 $124B $94.89 $1.61 2.18M 1.31B

AstraZeneca Financials Summary

In Thousands,
USD
TTM
30-Sep-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 132,068,052 112,692,471 101,489,615 84,488,797
Revenue 24,137,000 22,090,000 22,465,000 23,002,000
EBITDA 5,583,000 5,532,000 5,364,000 6,542,000
Net Income 2,056,000 2,155,000 3,001,000 3,499,000
Total Assets 58,906,000 60,651,000 63,354,000 62,526,000
Total Debt 18,158,000 19,113,000 17,807,000 16,808,000
Public Fundamental Data provided by Morningstar, Inc. disclaimer

AstraZeneca Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore AstraZeneca‘s full profile, request access.

Request full access to PitchBook

AstraZeneca Competitors (39)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Novartis Corporate Backed or Acquired Basel, Switzerland 000000 000000000000
00000 & 00. Corporation Kenilworth, NJ 00000
000000000000000 Corporation Brentford, United Kingdom 000000 00000000000
00000000 Corporate Backed or Acquired Dublin, Ireland 0000 000000&0
000000 00000 Corporation Mumbai, India 0000
To view this company’s complete list of competitors, request access »

AstraZeneca Investments & Acquisitions (60)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 000000 000 22-Aug-2019 000000000 00000 00 0000 Buildings and Property
000 000000000000 12-Jun-2019 00000 00000 00 00000 Biotechnology
000000 000000 23-Oct-2018 000000000 00000000 000.00 Biotechnology
00000000 05-Sep-2018 00000 00000 00 0000 Drug Delivery 0000000 00000 00.0
Circassia Pharmaceuticals 18-Jul-2018 PIPE 000.00 Distributors/Wholesale
To view this company’s complete investment and acquisition history, request access »

AstraZeneca Exits (5)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000000, 0000000 0 16-Dec-2015 000000000 00000 00 Completed
  • 00000000000
0000000 0000000000 23-Mar-2010 0000 00.00 Completed
  • 00000000000
0000000 0000000000 29-Sep-2009 0000 000 Completed
  • 00000000000
0000000 0000000000 12-Feb-2009 0000 00.00 Completed
  • 00000000000
KuDOS Pharmaceuticals 31-Jan-2006 Merger/Acquisition 00000 Completed
To view this company’s complete exits history, request access »

AstraZeneca Subsidiaries (11)

Company Name Industry Location Founded
Acerta Pharma Drug Discovery Oss, Netherlands 2012
00 000000 Drug Discovery Coppell, TX 0000
00000 000000000000 Therapeutic Devices Redwood City, CA 0000
0000 00000000 Biotechnology Waltham, MA 0000
00000000000 000000 Corporate Pension Södertälje, Sweden 0000
To view this company’s complete subsidiary history, request access »

AstraZeneca Executive Team (68)

Name Title Board
Seat
Contact
Info
Pascal Soriot Chief Executive Officer & Board Member
Marc Dunoyer Chief Financial Officer & Board Member
Jamie Freedman MD Head of Oncology & Global General Manager
Katarina Ageborg Chief Compliance Officer
David Smoley Chief Information Officer

35 Former Executives

You’re viewing 5 of 68 executives. Get the full list »

AstraZeneca Board Members (17)

Name Representing Role Since Contact
Info
000000è00 000000 00.0 Self Board Member 000 0000
000000 000000000 Self Board Member 000 0000
0000 000000000 Self Non-Executive Chairman of the Board 000 0000
0000 0000000 AstraZeneca Chief Financial Officer & Board Member 000 0000
000000 0000000000 Self Board Member 000 0000

8 Former Board Members

You’re viewing 5 of 17 board members. Get the full list »